Related Experiment Videos
Lymphocyte proliferation during PUVA therapy
Abstract:
The lymphocyte proliferation of 15 psoriatic patients was sutdied after stimulation with tuberculin, trichophytin, varidase, concanavalin A (Con A), and pokeweek mitogen (PMW) during the first and the eighth PUVA treatment, 2 h after oral intake of 8-methoxypsoralen (8-MOP), immediately after UVA-irradiation, and 24 h later. There was a significant decrease of the lymphocyte proliferation, after stimulation with Con A (P less than 0.05), trichophytin (P less than 0.01) and varidase (P less than 0.05), not with PWM and tuberculin, during the first PUVA treatment by 8-MOP alone. This decrease was not significantly changed by the following UVA irradiation and could not be demonstrated after 24 h. No dark effect of 8-MOP on the lymphocyte proliferation could be seen during the eighth treatment. 8-MOP seems to influence lymphocyte proliferation in the dark by interfering with the cell surface, not with the nucleus. The disappearence of this effect during PUVA therapy could be explained by a modification on the surface structure of lymphocytes.
Insights
Psoriatic patients showed decreased lymphocyte proliferation after 8-methoxypsoralen (8-MOP) intake during initial PUVA therapy. This effect, likely due to cell surface interaction, diminished with subsequent treatments, suggesting lymphocyte surface modification.
Area of Science:
- Immunology
- Dermatology
- Photochemotherapy
Background:
- Psoriasis involves immune dysregulation, with lymphocyte proliferation playing a key role.
- PUVA (psoralen plus UVA) therapy is a common treatment for psoriasis.
- The precise immunomodulatory effects of 8-methoxypsoralen (8-MOP) during PUVA therapy require further elucidation.
Purpose of the Study:
- To investigate the impact of 8-methoxypsoralen (8-MOP) on lymphocyte proliferation in psoriatic patients undergoing PUVA therapy.
- To determine if 8-MOP alone, or in combination with UVA irradiation, affects lymphocyte responsiveness to various mitogens and antigens.
Main Methods:
- Studied lymphocyte proliferation in 15 psoriatic patients.
- Stimulated lymphocytes with tuberculin, trichophytin, varidase, concanavalin A (Con A), and pokeweed mitogen (PWM).
- Assessed proliferation at various time points during the first and eighth PUVA treatments: after 8-MOP intake, immediately post-UVA, and 24 hours later.
Main Results:
- A significant decrease in lymphocyte proliferation was observed after 8-MOP intake during the first PUVA treatment when stimulated with Con A, trichophytin, and varidase.
- This suppressive effect of 8-MOP was not significantly altered by subsequent UVA irradiation or present after 24 hours.
- No 'dark effect' of 8-MOP on lymphocyte proliferation was detected during the eighth treatment, suggesting a modification in lymphocyte surface structure.
Conclusions:
- 8-methoxypsoralen (8-MOP) transiently inhibits lymphocyte proliferation in psoriatic patients during early PUVA therapy, potentially by interacting with the cell surface.
- The diminishing effect of 8-MOP during PUVA treatment may be attributed to adaptive changes in lymphocyte surface structures.
- These findings offer insights into the immunomodulatory mechanisms of PUVA therapy in psoriasis.